Unii-33Y9anm545
CAS: 635702-64-6
Ref. IN-DA00E9EW
1g | Discontinued | ||
5g | Discontinued | ||
10g | Discontinued | ||
100mg | Discontinued | ||
250mg | Discontinued |
- 5-membered Heterocycles
- 6-membered Heterocycles
- Active Pharmaceutical Ingredient (API) Related Compounds for Research
- Active Pharmaceutical Ingredients (API) for research
- Antitumoral
- Biochemicals and Reagents
- Cancer Research
- Cellular and Molecular Biology
- Enzyme Activators and Inhibitors
- Enzymes
- Indazoles
- Neuroscience
- Other Inhibitors
- Pyrazole
- Pyrimidine
- Tyrosine Kinase/Adaptors
- VEGFR
Product Information
Name:
Unii-33Y9anm545
Synonyms:
- [u'GW 780604', u'GW 786034B', u'GW-780604', u'GW-786034B', u'GW780604', u'GW786034B', u'pazopanib', u'Votrient', u'Pazopanib hydrochloride', u'635702-64-6', u'pazopanib HCl', u'Votrient', u'Pazopanib (Hydrochloride)', u'Armala', u'Pazopanib HCl (GW786034 HCl)', u'GW786034B', u'pazopanib monohydrochloride', u'GW 786034', u'GW786034 HCl', u'CHEBI:71217', u'33Y9ANM545', u'AK163181', u'S1035', u'C21H23N7O2S.HCl', u'5-((4-((2,3-DIMETHYL-2H-INDAZOL-6-YL)(METHYL)AMINO)PYRIMIDIN-2-YL)AMINO)-2-METHYLBENZENESULFONAMIDE HYDROCHLORIDE', u'5-((4-((2,3-Dimethyl-2H-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride', u'5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide hydrochloride', u'Patorma', u'Votrient (TN)', u'5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride', u'5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide hydrochloride', u'Pazopanib hydrochloride [USAN:JAN]', u'GW-786034B', u'Pazopanib-Hydrochloride', u'MLS004774147', u'SCHEMBL159487', u'SYN1058A', u'CHEMBL1201733', u'DTXSID70212956', u'EX-A956', u'MQHIQUBXFFAOMK-UHFFFAOYSA-N', u'Pazopanib HCl (GW786034 )', u'BCP02203', u'Pazopanib hydrochloride (JAN/USAN)', u'MFCD12546138', u'NSC737754', u'AKOS015958593', u'BCP9001052', u'CS-0126', u'GSK-786034', u'KS-1458', u'NSC-737754', u'PB31655', u'SB10367', u'KS-000003E0', u'AC-24726', u'AK-77387', u'AN-16933', u'HY-12009', u'SC-90768', u'SMR003500790', u'GW786034GW786034', u'AX8294838', u'AM20090655', u'FT-0687642', u'ST24048877', u'SW218082-2', u'X3177', u'EC-000.2347', u'D05380', u'W-5532', u'A834417', u'5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide Hydrochloride', u'5-({4-[(2,3-dimethylindazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride', u'5-[[4-[(2,3-dimethyl-6-indazolyl)-methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide hydrochloride', u'5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride', u'5-{4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino}-2-methyl-benzenesulfonamide hydrochloride', u'Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-, monohydrochloride', u'Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-, hydrochloride (1:1)', u'Pazopanib', u'cc-527', u'Pazopanib Hydrochloride [USAN]', u'GW786034', u'CS-CW-00177', u'Pazopanib Hydrochloride (GW786034)', u'ACN-041320', u'GW 786034B', u'CID11525740', u'GW780604', u'GW 780604', u'GW-780604', u'GW-786034', u'2631S', u'A8347', u'A10699', u'C516667', u'444731-52-6']
- 5-((4-((2,3-Dimethyl-2H-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride
- 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(Methyl)amino)pyrimidin-2-ylamino)-2-Methylbenzenesulfonamide hydrochloride
- 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide hydrochloride
- Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-,monohydrochloride
- Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-, hydrochloride (1:1)
- Gw 786034B
- Gw786034B
- Pazopanib HCl
- Unii-33Y9Anm545
- See more synonyms
- Votrient
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Indagoo
Long term storage:
Notes:
Chemical properties
Molecular weight:
473.9790
Formula:
C21H24ClN7O2S
Purity:
99%
Color/Form:
Solid
InChI:
InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H
InChI key:
MQHIQUBXFFAOMK-UHFFFAOYSA-N
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code: